Higa Tomohiro 4

What Happened
Tomohiro Higa, Senior Vice President, Finance at Tenaya Therapeutics (TNYA), sold a total of 3,469 shares on February 17, 2026 in three open-market transactions (611; 836; 2,022 shares). The weighted average sales price was $0.64 per share (range $0.6075–$0.671), for aggregate proceeds of approximately $2,231. The Form 4 indicates these sales were made to cover tax-withholding obligations tied to previously granted restricted stock units (RSUs).

Key Details

• Transaction date: 2026-02-17 (filed same day). Transaction type: Sale (code S).
• Shares sold: 611, 836 and 2,022 (total 3,469). Weighted average price: $0.64; price range: $0.6075–$0.671. Total proceeds ≈ $2,231. (Per footnote F2, reporting person can provide a breakdown of number of shares sold at each price on request.)
• Purpose: Shares sold to cover tax withholding for vested RSUs (footnotes F1, F4, F6).
• Unvested RSUs disclosed: includes 78,314; 76,376; and 71,688 shares that will be issued upon vesting (footnotes F3, F5, F7).
• Shares owned after the transactions are not specified in the provided excerpt.
• Filing timeliness: Report appears to have been filed on the same day as the transactions (not flagged late).

Context
These sales are reported as tax-withholding transactions tied to RSU vesting, a common and routine insider sale (treated as a non-investment-motivated disposition). Such transactions generally do not imply a change in the insider’s view of the company’s prospects; they simply satisfy tax obligations associated with vesting.